Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial results. "This is ...

Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics - A Global Market Overview" report has been ...

Bupivacaine (brand name Marcaine) and lidocaine (brand name Xylocaine) are common local anesthetics. They can numb parts of ...

One Million Patients Led to This Moment PRINCETON, N.J., Nov. /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of B ...

ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT ...

Pacira ended the third quarter of 2024 with cash, cash equivalents and available-for-sale investments ("cash”) of $453.8 ...